くすりのしおり

Injection
Published: 3/2017

The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.
Brand name :
OZAGREL Na Injection 20mg "TAKATA"
 Active ingredient:
Ozagrel sodium
 Dosage form:
injection
 Print on wrapping:

Effects of this medicine

This medicine inhibits thromboxane synthetase to suppress production of thromboxane A2, promotes production of prostacyclins, improves abnormality in balance between those two productions and suppresses platelet aggregation.
It is usually used to improve cerebrovascular spasms and associated symptoms of cerebral ischemia after surgery for subarachnoid hemorrhage and movement disorder associated with cerebral thrombosis (acute phase).

Before using this medicine, be sure to tell your doctor and pharmacist

  • If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
    If you have bleeding (hemorrhagic cerebral infarction, epidural bleeding, intracerebral bleeding, primary intraventricular bleeding), cerebral embolism, heart problem, conscious disorder or large infarction.
  • If you are pregnant or breastfeeding.
  • If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)

Dosing schedule (How to take this medicine)

  • Your dosing schedule prescribed by your doctor is ((        to be written by a healthcare professional))
  • To improve cerebrovascular spasms and associated symptoms of cerebral ischemia after surgery for subarachnoid hemorrhage: In general, this medicine is injected intravenously over a period of 24 hours continuously.
    To improve movement disorder associated with cerebral thrombosis (acute phase): In general, this medicine is injected intravenously over a period of 2 hours, twice a day.
  • In general, this medicine is administered for two consecutive weeks in any case.

Precautions while taking this medicine

Possible adverse reactions to this medicine

The most commonly reported adverse reactions include rash, hives, erythema, asthma(-like) attacks, itching, falling of blood pressure, anemia and fever. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
  • headache, subcutaneous bleeding, bloody urine [bleeding]
  • falling of blood pressure, respiratory distress, cold feeling [shock, anaphylactoid symptoms]
  • general malaise, loss of appetite, yellowing of the skin and the white of eyes [liver dysfunction, jaundice]
  • headache, fever, chills  [leucopenia, granulocytopenia]
  • swelling of face, decreased urine output, headache [renal dysfunction]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.

Storage conditions and other information

For healthcare professional use only : Day Month Year

For further information, talk to your doctor or pharmacist.

Keywords Search

 

 

 

 

Advanced Search

Browse by drug name A-Z
Browse by drug name A-Z